muscle
• myofiber hypertrophy and disorganization in 52-week old mutants
|
• peak aortic velocity, a measure of systolic performance, is greater at 10 weeks of age but is not maintained and is no different at 20 or 32 weeks of age and is reduced by 52 weeks of age, indicating an initial benefit to systolic function early in life but compromised performance in aged mice
• early/atrial peak filling velocity ratios are consistently lower in mutants
|
• exhibit an increase in the cross-sectional area of myofibers and a shift toward more oxidative fiber types (likely types 2A and 2X)
|
cardiovascular system
• myofiber hypertrophy and disorganization in 52-week old mutants
|
• cardiac mass and cardiac mass/tibial length ratio are significantly greater by 10 weeks of age and increase until 20 weeks of age
• 52-week old mutants show myofiber hypertrophy
|
• seen in older mutants (72 weeks of age)
|
• peak aortic velocity, a measure of systolic performance, is greater at 10 weeks of age but is not maintained and is no different at 20 or 32 weeks of age and is reduced by 52 weeks of age, indicating an initial benefit to systolic function early in life but compromised performance in aged mice
• early/atrial peak filling velocity ratios are consistently lower in mutants
|
growth/size/body
N |
• exhibit normal body weight most likely due to normal (not elevated) IGF1 concentrations in the serum
|
• cardiac mass and cardiac mass/tibial length ratio are significantly greater by 10 weeks of age and increase until 20 weeks of age
• 52-week old mutants show myofiber hypertrophy
|
cellular
• seen in older mutants (72 weeks of age)
|